首页> 外文期刊>Drug safety: An international journal of medical toxicology and drug experience >Electronic Drug Interaction Alerts in Ambulatory Care: The Value and Acceptance of High-Value Alerts in US Medical Practices as Assessed by an Expert Clinical Panel.
【24h】

Electronic Drug Interaction Alerts in Ambulatory Care: The Value and Acceptance of High-Value Alerts in US Medical Practices as Assessed by an Expert Clinical Panel.

机译:门诊医疗中的电子药物相互作用警报:专家临床小组评估的高价值警报在美国医疗实践中的价值和接受度。

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Computerized physician order entry systems are known to improve patient safety in acute-care hospitals. However, as clinicians frequently override drug interaction and allergy alerts, their value in ambulatory care remains uncertain. Objective: The purpose of the study was to examine whether ambulatory care clinicians were more likely to accept drug-drug interaction alerts that an expert panel judged to be of high clinical value. Study Design: We convened an expert panel to examine drug-drug interaction alerts generated by 2872 clinicians in Massachusetts, Pennsylvania and New Jersey who used a common electronic prescribing system between 1 January 2006 and 30 September 2006. We selected 120 representative drug interaction alerts from the most commonly encountered class-class interactions. Measurements: The expert panel rated each alert based on the following categories: (i) strength of the scientific evidence; (ii) probability that the interaction would result in an adverse drug event (ADE); (iii) severity of typical and most serious ADEs; (iv) the likelihood that a clinician could act on the information; and (v) the overall value of the alert to the average primary care clinician. We then used multivariate regression techniques to examine the relationship between the alert acceptance rate and the expert panel's mean rating of each category. Results: The decision of clinicians to accept drug interaction alerts increased (relative to a baseline alert acceptance rate of 8.8%) by 2.7% (95% CI 0.4, 5.1) for interactions that panelists judged would result in an ADE, by 2.3% (95% CI 0.9, 3.7) when primary care providers (PCPs) lacked prior knowledge about the information presented in the alert, and by 3.3% (95% CI 0.9, 5.8) when the PCP could readily act on the information provided in the alert. Conclusion: The value of electronic drug interaction alerts is influenced heavily by clinicians' judgements about the clinical value of the alert. Expert judgement should be taken into account when developing electronic decision support.
机译:背景:众所周知,计算机医师医嘱输入系统可以提高急诊医院的患者安全性。但是,由于临床医生经常忽视药物相互作用和过敏警报,因此其在非卧床护理中的价值仍不确定。目的:该研究的目的是检查门诊护理临床医生是否更可能接受专家小组认为具有较高临床价值的药物相互作用。研究设计:我们召集了一个专家小组来研究由马萨诸塞州,宾夕法尼亚州和新泽西州的2872名临床医生在2006年1月1日至2006年9月30日期间使用通用的电子处方系统产生的药物相互作用警报。我们从2006年1月1日选择了120个代表性药物相互作用警报最常遇到的类间交互。度量:专家小组根据以下类别对每个警报进行评分:(i)科学证据的强度; (ii)相互作用会导致药物不良事件(ADE)的可能性; (iii)典型和最严重的ADE的严重程度; (iv)临床医生可以对信息采取行动的可能性; (v)对普通初级保健临床医生的警报的总体价值。然后,我们使用多元回归技术来检查警报接受率与专家组每个类别的平均评分之间的关​​系。结果:对于专家小组成员认为会导致ADE的相互作用,临床医生接受药物相互作用警报的决定增加了2.7%(相对于基线警报接受率为8.8%)(95%CI 0.4,5.1)。 95%CI 0.9,3.7)时初级保健提供者(PCP)缺乏对警报中提供的信息的先验知识; 3.3%(95%CI 0.9,5.8)当PCP可以根据警报中提供的信息采取行动时。结论:电子药物相互作用警报的价值在很大程度上取决于临床医生对警报的临床价值的判断。开发电子决策支持时,应考虑专家的判断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号